Cargando…

Genetic dissection of intratumor heterogeneity of PD‐L1 expression in EGFR ‐mutated lung adenocarcinoma

In this study, we investigated the association between PD‐L1 expression in tumor cells and underlying genetic mutations, which was analyzed in detail using laser microdissection and next‐generation sequencing analysis. To investigate whether driver mutations are involved in the background of PD‐L1 e...

Descripción completa

Detalles Bibliográficos
Autores principales: Kunimasa, Kei, Hirotsu, Yosuke, Amemiya, Kenji, Honma, Keiichiro, Nakamura, Harumi, Nishino, Kazumi, Omata, Masao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10396783/
https://www.ncbi.nlm.nih.gov/pubmed/37442887
http://dx.doi.org/10.1111/1759-7714.15038
_version_ 1785083839553470464
author Kunimasa, Kei
Hirotsu, Yosuke
Amemiya, Kenji
Honma, Keiichiro
Nakamura, Harumi
Nishino, Kazumi
Omata, Masao
author_facet Kunimasa, Kei
Hirotsu, Yosuke
Amemiya, Kenji
Honma, Keiichiro
Nakamura, Harumi
Nishino, Kazumi
Omata, Masao
author_sort Kunimasa, Kei
collection PubMed
description In this study, we investigated the association between PD‐L1 expression in tumor cells and underlying genetic mutations, which was analyzed in detail using laser microdissection and next‐generation sequencing analysis. To investigate whether driver mutations are involved in the background of PD‐L1 expression, the EGFR major activating mutation was selected as the most frequent driver mutation. Surgical resection specimens were used to extract sufficient amounts of nucleic acids for analysis, and the high tumor proportion score (TPS:100%) and low (TPS: 0%) PD‐L1‐expressing parts of the tumor were each laser microdissected to examine the association between PD‐L1 expression heterogeneity and genetic mutations within the same tumor. The association between PD‐L1 heterogeneity and gene mutations within the same tumor was investigated. Analysis showed no association between PD‐L1 expression heterogeneity and genetic variants, which were found to be almost identical. However, PD‐L1 expression was found to be associated with the number of tumor infiltrating lymphocytes (TILs) present in the tumor, which may be related to whether or not lymphocytes can infiltrate into the tumor depending on the tumor histological type (solid pattern, lepidic pattern, etc.) and other factors.
format Online
Article
Text
id pubmed-10396783
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley & Sons Australia, Ltd
record_format MEDLINE/PubMed
spelling pubmed-103967832023-08-04 Genetic dissection of intratumor heterogeneity of PD‐L1 expression in EGFR ‐mutated lung adenocarcinoma Kunimasa, Kei Hirotsu, Yosuke Amemiya, Kenji Honma, Keiichiro Nakamura, Harumi Nishino, Kazumi Omata, Masao Thorac Cancer Brief Report In this study, we investigated the association between PD‐L1 expression in tumor cells and underlying genetic mutations, which was analyzed in detail using laser microdissection and next‐generation sequencing analysis. To investigate whether driver mutations are involved in the background of PD‐L1 expression, the EGFR major activating mutation was selected as the most frequent driver mutation. Surgical resection specimens were used to extract sufficient amounts of nucleic acids for analysis, and the high tumor proportion score (TPS:100%) and low (TPS: 0%) PD‐L1‐expressing parts of the tumor were each laser microdissected to examine the association between PD‐L1 expression heterogeneity and genetic mutations within the same tumor. The association between PD‐L1 heterogeneity and gene mutations within the same tumor was investigated. Analysis showed no association between PD‐L1 expression heterogeneity and genetic variants, which were found to be almost identical. However, PD‐L1 expression was found to be associated with the number of tumor infiltrating lymphocytes (TILs) present in the tumor, which may be related to whether or not lymphocytes can infiltrate into the tumor depending on the tumor histological type (solid pattern, lepidic pattern, etc.) and other factors. John Wiley & Sons Australia, Ltd 2023-07-13 /pmc/articles/PMC10396783/ /pubmed/37442887 http://dx.doi.org/10.1111/1759-7714.15038 Text en © 2023 The Authors. Thoracic Cancer published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Brief Report
Kunimasa, Kei
Hirotsu, Yosuke
Amemiya, Kenji
Honma, Keiichiro
Nakamura, Harumi
Nishino, Kazumi
Omata, Masao
Genetic dissection of intratumor heterogeneity of PD‐L1 expression in EGFR ‐mutated lung adenocarcinoma
title Genetic dissection of intratumor heterogeneity of PD‐L1 expression in EGFR ‐mutated lung adenocarcinoma
title_full Genetic dissection of intratumor heterogeneity of PD‐L1 expression in EGFR ‐mutated lung adenocarcinoma
title_fullStr Genetic dissection of intratumor heterogeneity of PD‐L1 expression in EGFR ‐mutated lung adenocarcinoma
title_full_unstemmed Genetic dissection of intratumor heterogeneity of PD‐L1 expression in EGFR ‐mutated lung adenocarcinoma
title_short Genetic dissection of intratumor heterogeneity of PD‐L1 expression in EGFR ‐mutated lung adenocarcinoma
title_sort genetic dissection of intratumor heterogeneity of pd‐l1 expression in egfr ‐mutated lung adenocarcinoma
topic Brief Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10396783/
https://www.ncbi.nlm.nih.gov/pubmed/37442887
http://dx.doi.org/10.1111/1759-7714.15038
work_keys_str_mv AT kunimasakei geneticdissectionofintratumorheterogeneityofpdl1expressioninegfrmutatedlungadenocarcinoma
AT hirotsuyosuke geneticdissectionofintratumorheterogeneityofpdl1expressioninegfrmutatedlungadenocarcinoma
AT amemiyakenji geneticdissectionofintratumorheterogeneityofpdl1expressioninegfrmutatedlungadenocarcinoma
AT honmakeiichiro geneticdissectionofintratumorheterogeneityofpdl1expressioninegfrmutatedlungadenocarcinoma
AT nakamuraharumi geneticdissectionofintratumorheterogeneityofpdl1expressioninegfrmutatedlungadenocarcinoma
AT nishinokazumi geneticdissectionofintratumorheterogeneityofpdl1expressioninegfrmutatedlungadenocarcinoma
AT omatamasao geneticdissectionofintratumorheterogeneityofpdl1expressioninegfrmutatedlungadenocarcinoma